The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.20 - Manufacture of pharmaceutical preparations
300 jobs Number of planned job creations
Announcement Date
10 January 2023
Employment effect (start)
1 February 2023
Foreseen end date
30 September 2024
Description
Chinese company Porton Pharma Solutions, the manufacturer of active pharmaceutical ingredients, plans to start production inLek (Novartis) and create 300 jobs in the next two years.
Porton, a supplier of pharma ingredients to Novartis, has decided to move its production closer to the buyer. For this purpose, it rents unused facilities in Mengeš from Lek, the Slovenian branch of Novartis. The investment of €50 million will serve for the establishment of laboratories and a pilot production facility. They are expected to be completed by September 2024. The Chinese company has also reserved land for eventual future expansion.
Novartis announced the sale of the Sandoz division, a manufacturer of generic drugs, in order to focus on core activities. Slovenian company Lek is a part of Sandoz but manufactures for both Sandoz and Novartis. Lek thus faces an uncertain future with the separation of Sandoz from Novartis.
According to Delo daily from 22 February 2023, the LEK management claimed the agreement was signed between Novartis and Porton.
Eurofound (2023), Porton Pharma Solutions, Business expansion in Slovenia, factsheet number 108180, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/108180.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...